The health condition of HIV-1 infected patients has improved during the last years, but lifelong antiretroviral treatment is still needed. However resistance, multiple side effects and drug to drug interactions of antiretrovirals challenge the establishment of a long lasting regimen. The average running time of each antiretroviral drug composing the therapy episodes combination antiretroviral therapy (cART) may be seen as an indicator of effectiveness and tolerability.

Schülter, E., Kaiser, R., Zazzi, M., Sönnerborg, A., Camacho, R., Verheyen, J. (2014). Time on drug analysis based on real life data. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 17, 19790.

Time on drug analysis based on real life data

ZAZZI, MAURIZIO;
2014-01-01

Abstract

The health condition of HIV-1 infected patients has improved during the last years, but lifelong antiretroviral treatment is still needed. However resistance, multiple side effects and drug to drug interactions of antiretrovirals challenge the establishment of a long lasting regimen. The average running time of each antiretroviral drug composing the therapy episodes combination antiretroviral therapy (cART) may be seen as an indicator of effectiveness and tolerability.
2014
Schülter, E., Kaiser, R., Zazzi, M., Sönnerborg, A., Camacho, R., Verheyen, J. (2014). Time on drug analysis based on real life data. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 17, 19790.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/974432